Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services
Is Ipamorelin legal in India?
Not approved as a medicine here.
Ipamorelin is a growth-hormone secretagogue peptide that has not completed development as a medicine. The CDSCO expert-committee records reviewed (2015 to September 2026) show no marketing application or permission for it. Under the New Drugs and Clinical Trials Rules, 2019, a drug that the Central Licensing Authority has not approved is a 'new drug' and may not be made for sale or distribution without permission, and CDSCO has used this rule to direct State Drug Controllers to act against other unapproved products (for example, enclomiphene in August 2026). I found no CDSCO notice naming this specific substance, so it is listed as not approved rather than prohibited. The WADA 2026 Prohibited List names ipamorelin among banned growth hormone secretagogues at all times.
Last verified 2026-09-29 · how we verify
Ipamorelin elsewhere
Sources (4)
- 01Manufacturing and marketing of unapproved drug products containing Enclomiphene and its combinations (sets out the New Drugs rule for unapproved products)Central Drugs Standard Control Organisation (CDSCO) · 2026-08-10 · accessed 2026-09-29
- 02CDSCO Subject Expert Committee (SEC) recommendations index (records reviewed 2015 to September 2026)Central Drugs Standard Control Organisation (CDSCO) · 2026-09-23 · accessed 2026-09-29
- 03Public Notice dated 18 May 2026: injectable preparations do not fall under the definition of cosmeticsCentral Drugs Standard Control Organisation (CDSCO) · 2026-05-18 · accessed 2026-09-29
- 04World Anti-Doping Code International Standard: Prohibited List 2026World Anti-Doping Agency · 2025-09 · accessed 2026-09-29